Evaluating the clinical trends and benefits of low‐dose computed tomography in lung cancer patients

BACKGROUND: Despite guideline recommendations, utilization of low‐dose computed tomography (LDCT) for lung cancer screening remains low. The driving factors behind these low rates and the real‐world effect of LDCT utilization on lung cancer outcomes remain limited. METHODS: We identified patients di...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Edmund M., Voora, Rohith S., Nalawade, Vinit, Kotha, Nikhil V., Qian, Alexander S., Nelson, Tyler J., Durkin, Michael, Vitzthum, Lucas K., Murphy, James D., Stewart, Tyler F., Rose, Brent S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525167/
https://www.ncbi.nlm.nih.gov/pubmed/34528761
http://dx.doi.org/10.1002/cam4.4229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525167/
https://www.ncbi.nlm.nih.gov/pubmed/34528761
http://dx.doi.org/10.1002/cam4.4229

Ejemplares similares